INTRODUCTION
Many peptide hormones require a C-terminal amide moiety for full biological activity [1, 2] . The enzymic formation of Cterminally amidated peptides from their glycine-extended precursors is a two-step process catalysed by two enzymic activities, namely peptidylglycine mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5), as shown in Scheme 1 [3] [4] [5] [6] [7] . The mono-oxygenase, PAM, catalyses the production of the α-hydroxyglycine derivative of the glycineextended precursor in a process dependent upon ascorbate, copper and molecular oxygen. The lyase, PGL, mediates the conversion of the α-hydroxyglycine derivative into C-terminally amidated peptide and glyoxylate.
Amidating enzymes, which have been isolated from various tissues and species [8] [9] [10] [11] [12] , exist as monofunctional proteins
Scheme 1 Enzymic formation of C-terminally amidated peptides from their glycine-extended precursors
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acetylphenylalanyl acrylate), has little to no effect on the kinetic parameters of the lyase domain of the AE from Xenopus lae is. Similarly, inhibition of the lyase domain by the potent dioxo inhibitor 2,4-dioxo-5-acetamido-6-phenylhexanoate has little effect on the activity of the monooxygenase domain in the bifunctional enzyme. A series of experiments on intermediate accumulation and conversion were also carried out, along with kinetic investigations of the reactivities of the monofunctional and bifunctional forms of PAM and PGL towards substrates and inhibitors. Taken together, the results demonstrate the kinetic independence of the mono-oxygenase and lyase domains, and provide no evidence for substrate channelling between these domains in the bifunctional amidating enzyme.
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which contain only the mono-oxygenase or the lyase, as well as bifunctional proteins containing both enzymic activities. Previous work has shown that, by the expression of truncated peptide amidating enzyme cDNAs, which encode only one enzymic domain, monofunctional mono-oxygenase or lyase protein can be produced, and that the catalytic activities of these monofunctional proteins are independent of each other [3, 4, [13] [14] [15] [16] [17] [18] . Furthermore, Husten et al. demonstrated that endoprotease treatment of a bifunctional amidating enzyme (AE) increased the mono-oxygenase activity 2-2.5-fold [18] . Cleavage between the mono-oxygenase and lyase domains was not required for this increase in mono-oxygenase activity, but removal of a noncatalytic C-terminal region was sufficient for the increase, consistent with catalytic independence of the two domains. Sequential reactions in biochemical processes are often catalysed by either multienzyme complexes, in which the enzymic activities are found on separable proteins, or multifunctional enzymes, which contain all the requisite enzymic activities on a single polypeptide chain. In both types of multifunctional systems, reaction intermediates may be ' channelled ' from one reaction site to the next without entering the bulk solution. Such substrate channelling has been reported to occur in the tryptophan synthase system [19] [20] [21] and the polyketide biosynthetic enzymes [22] . CAD, the multifunctional enzyme which catalyses the first three reactions of pyrimidine biosynthesis, exhibits efficient [23] , but possibly incomplete [24] , substrate channelling. Channelling is sometimes quite leaky, as in the lumazine synthase-riboflavin synthase complex [25] and the methylenetetrahydrofolate dehydrogenase-cyclohydrolase system [26, 27] ; in both cases approximately half of the intermediate is channelled, with the remaining intermediate being released into the bulk solution. In the cases of bifunctional GlmU protein [28] and phosphoribosyl-anthranilate isomerase-indoleglycerolphosphate synthase from Escherichia coli [29, 30] , substrate channelling either does not occur or is extremely inefficient.
We have previously demonstrated that PAM and PGL exhibit tandem reaction stereospecificities in carrying out the two requisite steps of C-terminal amidation, with PAM producing exclusively α-hydroxyglycine moieties of absolute configuration (S), and PGL being reactive only toward (S)-α-hydroxyglycines [5, 31] . This stereochemical consistency raises the possibility that substrate channelling might occur between the mono-oxygenase and lyase domains of the bifunctional forms of enzymes catalysing C-terminal peptide amidation. We have therefore carried out a series of experiments designed to investigate this issue. Selective targeting or quenching of each individual enzymic activity, as well as kinetic experiments on intermediate accumulation and conversion, were utilized to investigate the possibility of substrate channelling between the mono-oxygenase and lyase domains. Our results clearly confirm the kinetic and functional independence of the mono-oxygenase and lyase domains, and we see no evidence for substrate channelling between the domains of AE. These results are inconsistent with the recent suggestions of a possible role for a bivalent metal atom in the transport of the α-hydroxy intermediate from the monooxygenase to the lyase active site [32] or the potential involvement of the lyase domain in release of the α-hydroxy intermediate into solution in AEs [33] .
EXPERIMENTAL Materials
All buffers, ascorbate oxidase (1390 units\mg) and TNM-FH insect medium were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). N,N-Dimethylphenylene-1,4-diamine (DMPD) and -ascorbic acid were obtained from Aldrich Chemical Co. (Milwaukee, WI, U.S.A.). Bovine liver catalase (65 000 units\mg) was purchased from Boehringer Mannheim (Indianapolis, IN, U.S.A.) and Coomassie Plus protein assay mix was from Pierce (Rockford, IL, U.S.A.). EX-CELL 401 insect medium was obtained from JRH Biosciences (Lenexa, KS, U.S.A.), and heat-inactivated fetal-bovine serum was from Atlanta Biologicals (Norcross, GA, U.S.A.). Antibiotic-antimycotic (100i) and Pluronic F-68 (10 %) solutions were from Life Technologies (Gaithersburg, MD, U.S.A.). Acetyl--Tyr--Val-Gly was from Peninsula Laboratories (Belmont, CA, U.S.A., and -Tyr--Val-Gly was from Bachem (Torrance, CA, U.S.A.). Ac--Phe-Gly [31] , Ac--Phe--Phe-Gly [31] , Ac--Phe-OCH # CO # H [31] , [(4-methoxybenzoyl)oxy]acetic acid [39] and the pyruvate-extended N-acetyl amino acids [16] were synthesized as described previously. N-Acetylphenylalanyl acrylate (N-AcPhe acrylate ; 5-acetamido-4-oxo-6-phenylhex-2-enoate) was generously given by Dr. Corinne E. Mounier-Lee of our laboratory. All other chemicals were of the highest quality available.
Methods
HPLC analyses were performed on a Spherisorb C ) reversedphase column (Alltech), using an LDC Constametric III system outfitted with an LDC Spectromonitor 3100 variable-wavelength detector. Product quantification was by standard curves based on peak height. The elution buffer for trinitrophenyl (TNP)-labelled compounds was acetonitrile\water\trifluoroacetic acid (44 : 56 : 0.1, by vol.) with detection at 344 nm [4] . The elution buffer for (4-nitrobenzyl)thionylacetic acid was 50 mM ammonium acetate buffer (pH 5.5)\acetonitrile (17 : 3,v\v) with detection at 280 nm. PAM and PGL assays were carried out as described previously [3, 4, 39, 40] with the following modifications. In the continuous PAM assay, a 295-nm-UV-cut-off filter was used, and the increase in absorbance at 514 nm due to the oxidation of DMPD was recorded every 2 or 5 s for a total period of 120 or 200 s. Values for V max and K m were obtained from the inverse plots by using the least-squares-fit program EnzymeKinetics (Trinity Software, Campton, NH, U.S.A.). Inhibition parameters were calculated using the curve-fitting program SigmaPlot (Jandel Scientific, San Rafael, CA), to perform an iterative fit of the data to the appropriate form of the Michaelis-Menten equation. Dixon plots (1\ versus [I]) were used to determine inhibition type.
Insect cell culture
Spodoptera frugiperda (Sf9) cells (A.T.C.C. CRL1711) were maintained at 27 mC in monolayer and suspension cultures in TNM-FH medium supplemented with 10 % fetal-bovine serum and 10 ml\l antibiotic-antimycotic solution (100i). The cells were subcultured twice a week. After infection with a recombinant baculovirus, the medium was replaced by the serum-free medium, EX-CELL 401, supplemented with the above antibiotics and 0.1 % Pluronic F-68.
The recombinant baculovirus vectors for the monofunctional and bifunctional Xenopus lae is skin amidating enzymes were obtained from Dr. Y. Nishikawa [36] [37] [38] . Amplification was accomplished by infecting Sf9 cultures at a multiplicity of infection of 0.1 plaque-forming unit (p.f.u.)\cell and expression by infecting at a multiplicity of infection of 10 p.f.u.\cell. Media was collected 4 days post infection by centrifugation.
Enzyme isolations
Four forms of the X. lae is amidating enzymes were expressed. As can be seen in Table 1 , enzyme activity levels in the culture media were lower for the full AE (X. lae is AE) than for the monofunctional enzymes (X. lae is PAM and PGL) and the AE with a truncated transmembrane domain (X. lae is dAE), consistent with the results of Iwasaki et al. [37] . While the protein levels are similar across the enzyme forms, the specific activity is consistently much lower for the full AE.
X. lae is PAM, PGL and dAE were isolated at 4 mC as follows. The medium supernatant was diluted (2 : 1) with deionized water and applied to a sulphopropyl (SP)-Sepharose Fast Flow column (1.6 cmi90 cm, Pharmacia) equilibrated with 50 mM sodium Mes buffer, pH 6.2. Elution was achieved with a linear NaCl gradient (0-0.5 M). The concentrated material was applied to a * The medium supernatant is the resulting supernatant after the collected media has been centrifuged to remove cellular debris.
† One munit of PAM activity is defined as the amount of enzyme required to produce 1 nmol of TNP-D-Tyr-Val-(S )-α-hydroxy-Gly/min at 37 mC ; one munit of PGL activity is defined as the amount of enzyme required to produce 1 nmol of TNP-D-Tyr-Val-NH 2 /min at 37 mC.
‡ Bifunctional amidating enzyme with a truncated transmembrane domain [37] .
Mono Q HR 5\5 column (Pharmacia) which was equilibrated in 50 mM Tris\HCl buffer, and eluted with a stepwise NaCl gradient. The concentrated Mono Q pool was loaded on to a Superose 6 or 12 HR 10\30 column (Pharmacia) and eluted with 50 mM Hepes buffer, pH 7.0, containing 200 mM NaCl. Active fractions were pooled, concentrated and stored in 50 % (v\v) ethylene glycol at k20 mC and used as purified enzyme. The full X. lae is AE was isolated by a modification of this procedure. The medium supernatant dilution and SP-Sepharose chromatography were carried out in 50 mM sodium acetate buffer, pH 5.5. The concentrated SP-Sepharose pool was loaded on to two Superose 12 HR 10\30 columns connected in series and eluted with 50 mM Hepes buffer, pH 7.0, containing 200 mM NaCl. Bovine pituitary PAM and PGL were isolated from the neurointermediate tissue of mature bovine pituitaries as described previously [3, 4] .
Bifunctional time-course experiments
Assays were performed in 100 mM sodium Mes buffer, pH 6.5, containing 100 µM TNP--Tyr-Val-Gly, 4 µM CuSO % , 1 mg\ml catalase, 4 mM -ascorbic acid and enzyme in a total volume of 3 ml at 37 mC. A 100 µl aliquot was withdrawn from the incubation mixture at the appropriate time, quenched with 10 µl of 3 M HClO % , centrifuged, and analysed quantitatively by HPLC for TNP--Tyr-Val-α-hydroxy-Gly and TNP--Tyr-Val-NH # . In experiments where the in situ generation of TNP--TyrVal-α-hydroxy-Gly was desired, ascorbate oxidase was used to quench the mono-oxygenase reaction. The conversion of the TNP--Tyr-Val-α-hydroxy-Gly into amide was monitored by HPLC.
Selective time-dependent inactivation of the mono-oxygenase domain of the AE by N-Ac-Phe acrylate
Selective inactivation of mono-oxygenase domain of the AE by N-Ac-Phe-acrylate was determined by the dilution method [34] . Inactivation reactions in 100 mM sodium Mes buffer, pH 6.5, containing 4 µM CuSO % , 4 mM ascorbate, 1 mg\ml catalase, 0.2 % Triton X-100, 60 mM KI, purified AE, and various concentrations of N-Ac-Phe acrylate in a total volume of 540 µl were incubated at 37 mC. The inactivation reactions were initiated by the addition of N-Ac-Phe acrylate. Aliquots of 10 µl were withdrawn from the inactivation mixtures at 100 s intervals and diluted into 0.5 ml of the appropriate assay solution. Assay solutions for residual mono-oxygenase activity contained 4 µM CuSO % , 4 mM ascorbate, 1 mg\ml catalase, 60 mM KI and an excess amount of TNP--Tyr-Val-Gly (26 µM) in 100 mM sodium Mes buffer, pH 6.5. Assay solutions for residual lyase activity contained an excess amount of TNP--Tyr-Val-α-hydroxy-Gly (100 µM) in 100 mM sodium Mes buffer, pH 6.5. After 30 min of incubation at 37 mC, the residual assay reactions were quenched by the addition of 50 µl of 3 M HClO % , the mixtures being centrifuged then analysed quantitatively by HPLC. Kitz and Wilson plots were used to determine the values of K I and k inact .
The effect of N-Ac-Phe acrylate on the full AE reaction time course was investigated by pre-incubating the full AE in the absence or presence of 100 µM N-Ac-Phe acrylate as described above for the dilution method. An aliquot (100 µl) was withdrawn from the appropriate inactivation mixture after 30 min and added to the appropriate assay solution. Mono-oxygenase activity assays contained 4 µM CuSO % , 4 mM ascorbate, 1 mg\ml catalase, 60 mM KI and 26 µM TNP--Tyr-Val-Gly in 100 mM sodium Mes buffer, pH 6.5, in a total volume of 2.5 ml. Lyase activity assays contained 100 µM TNP--Tyr-Val-α-hydroxyGly in 100 mM sodium Mes buffer, pH 6.5, in a total volume of 2.5 ml. The assay mixtures were incubated at 37 mC. Aliquots (100 µl) were withdrawn over time, quenched with 10 µl of 3 M HClO % , centrifuged, and analysed quantitatively by HPLC for TNP--Tyr-Val-α-hydroxy-Gly and TNP--Tyr-Val-NH # .
RESULTS

Recombinant amidating enzymes
Four forms of the X. lae is amidating enzymes were expressed in the Sf9\BEV system : the full AE (X. lae is AE), the AE with a truncated transmembrane domain (X. lae is dAE) and the monofunctional mono-oxygenase and lyase (X. lae is PAM and PGL). Kinetic parameters for these enzymes as well as the corresponding monofunctional bovine enzymes are shown in Table 2 . It is evident from the Table that the kinetic parameters for the mono-oxygenase and lyase activities of the various enzyme forms towards peptide substrates are quite similar. The full AE, X. lae is AE, generally has lower K m values for the entire glycine-extended substrate series. This is consistent with the results of Husten et al. in which the rat AE had a slightly lower K m value for Ac-Tyr-Val-Gly (14 µM) than that of the monofunctional mono-oxygenase (18 µM) [18] . Kinetic experiments were also carried out to compare the K m values of the in i o electron donor, -ascorbate [9] , and that of the alternative electron donor, DMPD, towards the various enzyme forms. The K m values obtained using peptide substrates for both electron donors were approx. 1-2 mM for all forms of the monooxygenase enzyme. The first potent inhibitors for bovine pituitary PGL were recently introduced by this laboratory [16] ; these compounds are 2,4-dioxo-5-acetamidoalkanoic acid derivatives (or, more simply, pyruvate-extended N-acetylamino acid derivatives). As shown in Table 2 , these dioxo compounds are potent competitive inhibitors for the lyase domain of both the monofunctional and bifunctional X. lae is skin enzymes. 2,4-Dioxo-5-acetamido-6-phenylhexanoate (N-Ac-Phe pyruvate) is the most potent of these dioxo lyase inhibitors, with K I values in the 50 nM range. In addition, these pyruvate-extended N-acetylamino acid derivatives also bind to the ascorbate site in ascorbate-dependent mono-oxygenases, such as PAM and dopamine β-mono-oxygenase, giving rise to inhibition that is competitive with respect to ascorbate and uncompetitive with respect to the organic substrates [16] . However, pyruvate-extended N-acetylamino acid derivatives possessing hydrophobic side chains are much more potent inhibitors of the lyase than of the mono-oxygenase ; thus the data in Table 2 demonstrate that N-Ac-Phe pyruvate is a 1000-fold more potent an inhibitor for X. lae is PGL than for X. lae is PAM.
The X. lae is PAMs are also capable of catalysing the alternate mono-oxygenase reaction, sulphoxidation (Table 2) , as previously reported for the bovine enzyme by Katopodis and May [34] . This sulphoxidation reaction is much less facile than the corresponding α-hydroxylation reaction that occurs with glycineextended peptide substrates. As is evident from Table 2 , the V max,app values are 24-fold (bovine PAM) to 370-fold (X. lae is dAE) greater for TNP--Tyr-Val-Gly than for the sulphoxidation of (4-nitrobenzyl)thioacetic acid, and the V max,app \K m ratios of TNP--Tyr-Val-Gly\(4-nitrobenzyl)thioacetic acid range from 1.2i10$ (bovine PAM) to 35i10$ (X. lae is dAE). Since the chemical reactivity of sulphur toward mono-oxygenase-catalysed oxygenation would be expected to be much greater than that of carbon [39, 40] , this probably reflects altered substrate positioning in the active site. In this regard, we note that PAM exhibits high S # -subsite stereospecificity, with both substrate reactivity and inhibitor binding being markedly decreased by the presence of either a -amino acid residue or a (R)-mandelyl residue at the P # position [31] othe nomenclature for the substrate residues, or analogues (P " , P # , etc.) and the corresponding enzyme subsites (S " , S # , etc.) is the nomenclature originally proposed by Schechter and Berger [41] q. In the case of the sulphide substrate, the positioning of the aromatic substituent is obviously altered from that of the side chain of an -amino acid side chain such as -Phe, resulting in diminished reactivity.
Reactivity of the lyase domain in the presence of monooxygenase inhibitors
Efficient substrate channelling has been shown to occur in the tryptophan synthase system [19] [20] [21] and, in this system, binding of a substrate analogue at one site can have a dramatic effect on the kinetic parameters for catalysis at the other site [42] . We have previously shown that esters are potent competitive inhibitors of PAM ; typical K I values are 45 µM for the peptide inhibitor N-Ac--Phe-OCH # CO # H [31] and 160 µM for the aryl ester inhibitor [(4-methoxybenzoyl)oxy]acetic acid [34] . These potent ester inhibitors were therefore used to investigate the effect of inhibitor binding at the mono-oxygenase domain on the sub- strate reactivity of the lyase domain of AEs. As shown in Table  3 , inhibition of the mono-oxygenase domain by these ester inhibitors has no effect on K m and very little effect on V max for both forms of the AE.
Intermediate accumulation and product formation
The tryptophan synthase system, which exhibits efficient substrate channelling [19] [20] [21] , generates a reaction intermediate that is undetectable in the bulk solution, and no lag is observed in the time course of formation of the final product. Moreover, it has been demonstrated that intermediate added to the bulk solution is converted into the final product at a rate that is much lower than that of the channelled intermediate [19] . Therefore a series of experiments was carried out in order to explore the possibility of substrate channelling in the bifunctional X. lae is amidating enzyme, AE. hydroxy intermediate is easily detected and accumulates in the bulk solution, and there is an initial lag period before amide production ( Figure 1A, inset) . Clearly, this kinetic behaviour is sharply distinct from that observed in systems with substrate channelling.
As shown in Figure 1(B) , initial experiments demonstrated that addition of ascorbate oxidase to the normally functioning bifunctional amidating system immediately quenches monooxygenase turnover via oxidation of the requisite electron donor, -ascorbate, without affecting catalytic turnover at the lyase domain. It is evident from the Figure that, subsequent to ascorbate oxidase addition, no further production of TNP--Tyr-Val-α-hydroxy-Gly occurs, whereas formation of the final amide product continues unabated until all of the α-hydroxy intermediate is consumed. Therefore this ascorbate oxidase addition protocol was utilized to allow a quantitative comparison of the rates of conversion of the ' in-situ-generated ' and ' added ' intermediate to the final amide product by the bifunctional enzyme. It is evident from the results of this experiment, shown in Figure 2 , that the rates of TNP--Tyr-Val-α-hydroxy-Gly reaction in these two cases are identical. Moreover, in contrast with the normal reaction time course, conversion of the externally added α-hydroxy intermediate to amide commences immediately upon the addition of AE, with no lag whatsoever evident in the reaction time course. Taken together, these results establish kinetic behaviour for the AE which contrasts sharply with that reported for the tryptophan synthase system [19] .
Mono-oxygenase-catalysed sulphoxidation in the presence of a lyase inhibitor
Since the lyase domain does not process the sulphoxide product of mono-oxygenase-catalysed sulphoxidation, catalytic turnover of sulphide substrates reflects only the activity of the mono- oxygenase domain. Accordingly, we investigated the effect of inhibition of the lyase domain on sulphoxidation ; if the two domains are truly independent, the presence of a competitive lyase inhibitor should have no effect on enzymic sulphoxidation. As can be seen in Figure 3 , the presence of N-Ac-Phe-pyruvate under conditions where the activity of the lyase domain is completely inhibited has only a small effect on the rate of enzymic sulphoxidation. In contrast, as shown in the Figure, 
N-Ac-Phe acrylate as a selective mono-oxygenase inactivator
It has been previously reported that the olefinic substrate analogues, 4-phenylbut-3-enoic acid, trans-benzoylacrylic acid and monoethyl fumarate, have been shown to be mechanismbased inactivators of PAM [34, 43] . On the basis of these results, the novel olefinic compound N-Ac-Phe acrylate was synthesized in our laboratory as a potential PAM inactivator capable of enhanced binding at the active site owing to secondary binding interactions with the N-Ac-Phe moiety [44] . N-Ac-Phe acrylate is a time-dependent inactivator of the mono-oxygenase domain of the AE with weighted linear regression of the double-reciprocal plot of 1\k obs versus 1\[N-Ac-Phe acrylate] yielding a K I of 360p20 µM and a k inact of 1.47p0.07 min −" , whereas it does not inactivate the lyase domain.
We then proceeded to utilize N-Ac-Phe acrylate to investigate the effect of mechanism-based inactivation of the mono-oxygenase domain on the catalytic activity of the lyase domain. In these experiments, the full AE reaction time course was monitored after 30 min preincubation in the absence or presence of 100 µM N-Ac-Phe acrylate. The residual activity of each domain was followed by either reaction with TNP--Tyr-Val-Gly (monooxygenase activity) or reaction with TNP--Tyr-Val-(S)-α-hydroxy-Gly (lyase activity). Preincubation with N-Ac-Phe acrylate has virtually no effect on the rate of lyase-catalysed production of TNP--Tyr-Val-NH # from TNP--Tyr-Val-α-hydroxy-Gly (initial rate of 1.1 µM\min in both cases). Parallel experiments demonstrated that mono-oxygenase activity is completely abolished by preincubation with N-Ac-Phe acrylate, with production of TNP--Tyr-Val-α-hydroxy-Gly from TNP--TyrVal-Gly being virtually undetectable. These results represent further evidence for the kinetic independence of the two domains of the AE.
DISCUSSION
Four forms of the recombinant X. lae is amidating enzymes were expressed in the baculovirus system and investigated in the present study ; two of these forms are AEs, possessing both mono-oxygenase and lyase domains, while the remaining two forms were the soluble mono-oxygenase and lyase enzymes respectively. The kinetic parameters of all of these enzyme forms towards a series of substrates and inhibitors were determined ( Table 2 ). While some differences in K m , V max and K I were observed, these kinetic experiments revealed no evidence for kinetic interdependence or co-operativity between the monooxygenase and lyase domains of the AEs.
Our results further demonstrate that selective inhibition of either the mono-oxygenase or lyase domain has only a minimal effect on the kinetic parameters of the other domain of the AE. Thus the initial rate of production of TNP--Tyr-Val-α-hydroxyGly by the mono-oxygenase domain in the AE is unaffected when the lyase domain is completely inhibited by N-Ac-Phe pyruvate [16] . Similarly, inhibition of the mono-oxygenase domain by competitive ester inhibitors has no effect on K m and very little effect on V max for both forms of the AE. Furthermore, inactivation of the mono-oxygenase domain by the potent mechanism-based inactivator N-Ac-Phe acrylate, has no effect on the rate of the lyase-catalysed production of TNP--Tyr-Val-NH # from TNP--Tyr-Val-α-hydroxy-Gly. If the two domains are truly independent, the presence of a competitive lyase inhibitor should not affect the rate of sulphoxidation by the X. lae is bifunctional enzyme. This alternative mono-oxygenase reaction was chosen because the sulphoxide product is not acted upon by the lyase. Thus this system serves as an excellent substrate probe for mono-oxygenase turnover. Saturation of the lyase with N-Ac-Phe pyruvate, under conditions where the lyase domain is completely inhibited, has only a very small effect on enzymic sulphoxidation. Taken together, these results demonstrate that the mono-oxygenase and lyase domains of bifunctional X. lae is AE are kinetically independent.
When substrate channelling which entails direct transfer of an intermediate occurs in a multifunctional enzyme or multi-enzyme complex, there is no detectable lag between the sequential reactions [45] as in the tryptophan synthase system [19] . In contrast, in systems where substrate channelling does not occur, the product of the first reaction must find the second active site by free diffusion, resulting in a distinct lag [46] . This is the case for phosphoribosyl-anthranilate isomerase\indoleglycerol-phosphate synthase, where the intermediate, o-carboxyphenylaminodeoxyribulose phosphate, accumulates in the bulk solution, and there is a lag before the second reaction begins [29] . In the case of the amidating enzymes described here, the initial lag period before amide production, and the presence of the α-hydroxy intermediate in the bulk solution ( Figure 1A ), suggest that either there is no direct substrate channelling or that substrate channelling is extremely inefficient. An initial lag period before amide production and accumulation of the α-hydroxy intermediate are also evident in the data presented by Consalvo et al. for the reaction time course of dansyl-Tyr-Val-Gly with recombinant rat AE [47] .
An additional criterion which can be used to determine the extent of substrate channelling in a multifunctional system is an examination of the rate of conversion of added intermediate. Thus, in the bifunctional GlmU protein, externally added radiolabelled intermediate equilibrates in the bulk solution with the endogenous intermediate [28] , and in the phosphoribosyl-anthranilate isomerase\indoleglycerol-phosphate synthase system, addition of intermediate to the reaction mixture eliminates the initial lag in product formation [48] . These results have been used to confirm that substrate channelling does not occur in these two enzyme systems. In contrast with these results, in the tryptophan synthase system, which exhibits efficient substrate channelling, the added radiolabelled indole intermediate is turned over at least 25-fold more slowly than indole produced at the α active site [19] . The results reported here demonstrate that externally added intermediate is turned over by the lyase domain at a rate which is identical with that for the in-situ-generated intermediate. This result is consistent with the absence of a direct channelling mechanism between the mono-oxygenase and lyase domains of AEs.
Substrate channelling between the domains of multifunctional enzymes may serve as a protection mechanism for labile intermediates along a reaction pathway. In pyrimidine biosynthesis, carbamoyl phosphate is efficiently channelled between sequential active sites in CAD [23] , and this labile intermediate has a halflife of approx. 40 min under physiological conditions [24, 49] . In the formiminotransferase-cyclodeaminase system, substrate channelling is beneficial, because the concentration of N-5-formiminotetrahydrofolate, the labile intermediate with no other known metabolic function, is decreased [50] . Adenosine 5h-phosphosulphate, the labile intermediate of the bifunctional ATP sulphurylase-adenosine-5h-phosphosulphate kinase system, is channelled with almost 100 % channelling efficiency, and Lyle et al. suggested that channelling is a protection mechanism for the labile intermediate which is subject to both biochemical (sulphohydrolases) and spontaneous chemical degradation [51] . We have previously demonstrated the stability of acyl-α-hydroxyglycines under physiological conditions [16] , and thus substrate channelling of the α-hydroxy intermediate between the monooxygenase and lyase active sites of AEs would not be required for intermediate protection.
Bell et al. have recently investigated the possible structural and functional role of zinc in peptide amidation and determined by X-ray-absorption spectroscopy and 4-(2-pyridylazo)resorcinol analysis that recombinant rat AE contains a tightly bound Zn(II) [32] . They have further suggested that the ' extra ' bivalent-metalbinding site observed by Prigge et al. in the crystal structure of the PAM catalytic core [52] could be occupied by zinc in AE, and that this zinc atom may play a role in the transport of the α-hydroxy intermediate from the mono-oxygenase to the lyase active site [32] . Francisco et al. have also suggested the possibility of substrate channelling between the mono-oxygenase and lyase domains of the AE [33] . Isotope-effect studies on monofunctional and bifunctional mono-oxygenases indicate that release of the α-hydroxy intermediate occurs more slowly from the bifunctional mono-oxygenase, indicating potential involvement of the lyase domain in release of the α-hydroxy intermediate into solution [33] . However, our results do not indicate any mechanism of transport between the two active sites other than free diffusion through the bulk solution, and support the possibility that Zn plays either a structural role or is involved in PGL catalysis.
In different organisms, the enzyme systems catalysing sequential reactions may exist as individual monofunctional enzymes, multienzyme complexes or multifunctional enzymes. This has led to the idea that multifunctional enzymes may have evolved from small monofunctional proteins through multienzyme complexes to the covalent linkage of the C-terminus of one protein to the Nterminus of another, thus forming the multifunctional enzyme [46] . This evolutionary hypothesis would be supported if it could be demonstrated that individual enzymes which become covalently linked bestow a selective advantage to the organism, and biochemical and physicochemical investigations may reveal the molecular basis for such an advantage [46] . However, investigations to date have not yielded an explanation for the in i o existence of both mono-and bi-functional AEs. We note that the absence of substrate channelling opens up the possibility that, under physiological conditions with various peptides, steadystate or transient accumulation of α-hydroxy-glycinated peptides may occur. Whether or not such α-hydroxy-glycinated peptides exhibit distinct biological activities, as is apparently the case for the glycine-extended precursor of gastrin "( [53, 54] , remains to be determined.
